Keywords: اسید زولدرونیک; Denosumab; Zoledronic acid; Teriparatide; Bone remodeling; Wnt-inhibitors; Myostatin;
مقالات ISI اسید زولدرونیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اسید زولدرونیک; Mathematical modeling; Gelatin-graphene hydrogel; Drug release; Zoledronic acid; Hydrogel swelling;
Keywords: اسید زولدرونیک; Bone metastasis; Breast cancer; SRE; Pamidronate; Zoledronic acid; Biomarker; NTX; CTX; BSAP; BSP;
Keywords: اسید زولدرونیک; Bone metastasis; Bisphosphonate; Breast cancer; Cancer treatment-induced bone loss; Denosumab; Zoledronic acid;
Keywords: اسید زولدرونیک; BMs; bone metastases; BPI; Brief Pain Inventory; BTA; bone-targeted agent; CI; confidence interval; DSP; Disease Specific Programme; EQ-5D; 5-dimension (3-level) EuroQol questionnaire; ER; estrogen receptor; FACT-B; Functional Assessment of Cancer Therapy
Keywords: اسید زولدرونیک; NPs; nanoparticles; siRNA; small interfering RNA; miRNA; microRNA; DC-Chol; 3b(N-(N¢,N¢-dimethylaminoethane)carbarmoyl)-cholesterol; DOPE; dioleoylphosphatidylethnolamine; DMRIE; 1,2-dimyristyloxypropyl-3-dimethyl-hydroxyethyl ammonium bromide; DOTAP; 1
Keywords: اسید زولدرونیک; abiraterone; bone-targeted agents; castration-resistant prostate cancer; denosumab; electronic health records; enzalutamide; zoledronic acid;
Keywords: اسید زولدرونیک; 27-HC; 27-hydroxycholesterol; ER; estrogen receptor; CYP27A1; cytochrome P450, family 27, subfamily A, polypeptide 1; LXR; liver X receptor; BRCA1 and BRCA2; Breast cancer 1 and 2; LDL; low density lipoprotein; HDL; high density lipoprotein; ApoE; apolipo
Keywords: اسید زولدرونیک; Bisphosphonates; Alendronate; Zoledronic acid; Alzheimer's disease; Huntington's disease; Brain calcification;
Keywords: اسید زولدرونیک; Prostate cancer; Bisphosphonates; Abiraterone acetate; Denosumab; Zoledronic acid; Enzalutamide; Radium-223;
Keywords: اسید زولدرونیک; Zoledronic acid; renal epithelial cells; genotoxic effect; mitochondria; apoptosis; cytostasis;
Keywords: اسید زولدرونیک; Magnesium-strontium alloys; CaP coating; Zoledronic acid; Giant cell tumors of bone; Mechanisms;
Keywords: اسید زولدرونیک; Bisphosphonante; Zoledronic acid; Medical drug production; Exergy analysis; Waste minimization;
Keywords: اسید زولدرونیک; Denosumab; Zoledronic acid; Bone metastases; Gastrointestinal cancer; Pancreas-biliary system cancer; Rare cancers;
Keywords: اسید زولدرونیک; Cytoprotective effects; Melatonin; Zoledronic acid; Human osteoblasts; Bisphosphonate-related osteonecrosis of the jaw (BRONJ);
Keywords: اسید زولدرونیک; Zoledronic acid; Tooth extraction; Bone regeneration;
Keywords: اسید زولدرونیک; Osteogenesis imperfecta; Zoledronic acid; Sclerostin; Scl-Ab antibody; Col1a2 G610C;
Keywords: اسید زولدرونیک; Bone mineral density; bone-targeted therapy; denosumab; prostate cancer; radium-223; zoledronic acid;
Keywords: اسید زولدرونیک; Strontium; Hydroxyapatite; Zoledronic acid; Rat model; Osteoporosis;
Keywords: اسید زولدرونیک; Zoledronic acid; Bone loss; Total hip arthroplasty; Meta-analysis;
Keywords: اسید زولدرونیک; Skeletal-related event; Denosumab; Zoledronic acid; Bone metastases; Meta- analysis;
Keywords: اسید زولدرونیک; Bisphosphonates; Maintenance therapy; Multiple myeloma; Skeletal events; Zoledronic acid;
Keywords: اسید زولدرونیک; AI; aromatase inhibitor; BMD; bone mineral density; BMI; body mass index; Bone; Breast cancer; Chemotherapy; Multiple myeloma; Prostate cancer; Denosumab; Zoledronic acid;
Keywords: اسید زولدرونیک; BM; Kidney; RCC; TKI; Zoledronic acid;
Keywords: اسید زولدرونیک; Osteonecrosis of the jaw; Zoledronic acid; Osteoclast; Osteoblast; Alveolar bone; Basic multicellular unit
Keywords: اسید زولدرونیک; Zoledronic acid; Risedronic acid; Drug uptake; Breast cancer
Keywords: اسید زولدرونیک; Bone healing; Bone quality; Zoledronic acid; Parathyroid hormone; Micro-computed tomography; Raman spectroscopy;
Keywords: اسید زولدرونیک; Breast cancer; Statins; Zoledronic acid; Mevalonate pathway; Apoptosis; Rho-GTPases;
Keywords: اسید زولدرونیک; Bisphosphonate; BRONJ; Osteonecrosis of the jaw; Prostate cancer; Zoledronic acid;
Keywords: اسید زولدرونیک; BRONJ; Zoledronic acid; Bone metastasis
Keywords: اسید زولدرونیک; Antiresorptive therapy; Bisphosphonate; Receptor activator of nuclear factor κB ligand (RANKL) inhibitor (denosumab); Zoledronic acid; Pamidronate; Malignant bone disease; Osteolytic bone disease;
Keywords: اسید زولدرونیک; Lung cancer; Bisphosphonate; Zoledronic acid; Prenylation; Ras signalling;
Keywords: اسید زولدرونیک; Spine; Zoledronic acid; CKD-MBD; Anti-sclerostin antibody; PTH; Chronic kidney disease;
Keywords: اسید زولدرونیک; Dual-drug delivery system; Designed porous scaffold; Ibuprofen; Zoledronic acid; Co-delivery release; Tissue engineering;
Keywords: اسید زولدرونیک; bisphosphonates; hFOB 1.19; multicellular spheroids; proliferation; zoledronic acid
Keywords: اسید زولدرونیک; Adipose-derived stem cells; Platelet-rich plasma; Bisphosphonate-related osteonecrosis of the jaw; Zoledronic acid
Keywords: اسید زولدرونیک; Rat model; Postmenopausal osteoporosis; Zoledronic acid; PropranololEstudo com ratos; Osteoporose pós-menopáusica; Ácido zoledrônico; Propranolol
Keywords: اسید زولدرونیک; Disuse osteoporosis; Rat model; Zoledronic acid; AlfacalcidolOsteoporose por desuso; Estudo com ratos; Ácido zoledrônico; Alfacalcidol
Keywords: اسید زولدرونیک; Disuse osteoporosis; Rat model; Zoledronic acid; PropranololOsteoporose por desuso; Estudo com ratos; Ácido zoledrônico; Propranolol
Keywords: اسید زولدرونیک; Osteoporose por desuso; Estudo com ratos; Ácido zoledrônico; AlfacalcidolDisuse osteoporosis; Rat model; Zoledronic acid; Alfacalcidol
Keywords: اسید زولدرونیک; AA; abiraterone acetate; ADT; androgen deprivation therapy; AR; androgen receptor; AR-V; AR splice variant; CRPC; castration-resistant prostate cancer; CTC; circulating tumor cell; CYP; cytochrome P450; FDA; Food and Drug Administration; LBD; ligand-bindi
Keywords: اسید زولدرونیک; Zoledronic acid; Lumbar interbody fusion; Osteoporosis; Bisphosphonate; Pedicle screws; Lumbar spine
Keywords: اسید زولدرونیک; Zoledronic acid; Circulating neoplatic cells; Prostate neoplasms
Keywords: اسید زولدرونیک; Zoledronic acid; Osseointegration; Implant; Osteoporosis;
Keywords: اسید زولدرونیک; Bone morphogenetic protein; Zoledronic acid; Spine fusion; Rat model;
Keywords: اسید زولدرونیک; Bisphosphonates; Chlamydia pneumoniae; Cytokines; Cytotoxicity; Human osteosarcoma cells; Zoledronic acid
Keywords: اسید زولدرونیک; Bisphosphonates; Bone metastasis; Castration-resistant prostate cancer; Prostate-specific antigen; PSA kinetics; Skeletal complications; Zoledronic acid
Keywords: اسید زولدرونیک; Adjuvant therapy; Anticancer; Bisphosphonate; Bone mineral density; Breast cancer; Clodronate; Survival; Zoledronic acid;
Keywords: اسید زولدرونیک; Bisphosphonates; Alendronate; Zoledronic acid; Osseointegration; Osteoporosis;
Keywords: اسید زولدرونیک; Zoledronic acid; Bisphosphonate; rhBMP-2; Collagen; Hydroxyapatite;